Moderna, Inc. (MRNA) Q1 2026 Earnings Call

Investor webinar replay

Replay transcript excerpt

Good day, and thank you for standing by. Welcome to Moderna's first quarter 2026 conference call. At this time, all participants are on a listen-only mode. After the speaker's presentation, there'll be a question and answer session. To ask a question during the session, you'll need to press star 1-1 on your telephone. You will then hear an automated message advising your hand is raised. To withdraw your question, please press star 1-1 again. Please be advised, today's conference is being recorded. I would like to hand the conference over to your speaker today, Levina Tulukdar, head of IR. Please go ahead. Thank you, Kevin. Good morning, everyone, and thank you for joining us today to discuss Moderna's first quarter 2026 financial results and business updates. You can access the press release issued this morning as well as the slides that we'll be reviewing by going to the investor section of our website. On today's call are Stephane Boncel, our chief executive officer, Stephen Hogue, our president, and Jamie Mock, our chief financial officer. Please note that this conference call will include forward-looking statements made pursuant to the Safe Harbor provisions of the Securities Litigation Reform Act of 1995. Please see slide two of the accompanying presentation and our SEC filings for important risk factors that could cause our performance and results to differ materially from those expressed or implied in these forward-looking statements. With that, I will turn the call over to Stéphane. Thank you, Lavina. Good morning or good afternoon, everyone. Thank you for joining us today. I will start with a review of the first quarter. Jamie will then cover our financial results and outlook, followed by Stephen on commercial and clinical progress. I will close by discussin...